Revvity

سعر السهم
97.74
التغيير اليومي
2.69 2.83%
شهريا
-12.65%
سنويا
-15.02%
Q1 التوقعات
93.05




Ebit تغيير تاريخ
Agilent USD 443M 66M 2025-09
Align Technology USD 224.71M 40.06M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD -418.8M 845.4M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 512M 401M 2025-09
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Hologic USD 240.9M 12.1M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 382M 11M 2025-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -12.12M 3.97M 2023-06
Mesa Laboratories USD 4.45M 2.5M 2024-09
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -5.5M 11.1M 2025-03
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
OraSure Technologies USD -6M 13.22M 2024-09
Organigram Holdings CAD -28.05M 25.94M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pacific Biosciences Of California USD -73.51M 338K 2023-09
Pharma Mar EUR -3.96M 28.11M 2025-09
Qiagen NV USD 121.88M 19.18M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Quidel USD -37.3M 82.5M 2025-12
Repligen USD 16.81M 10.85M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Waters USD 270.52M 78.4M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 15.6M 2025-09


Revvity - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.